CN105002109B - 乳酸菌、包含该乳酸菌的组合物以及其用途 - Google Patents

乳酸菌、包含该乳酸菌的组合物以及其用途 Download PDF

Info

Publication number
CN105002109B
CN105002109B CN201510195767.9A CN201510195767A CN105002109B CN 105002109 B CN105002109 B CN 105002109B CN 201510195767 A CN201510195767 A CN 201510195767A CN 105002109 B CN105002109 B CN 105002109B
Authority
CN
China
Prior art keywords
lactic acid
acid bacteria
subject
purposes
functional
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
CN201510195767.9A
Other languages
English (en)
Chinese (zh)
Other versions
CN105002109A (zh
Inventor
蔡英杰
刘伟贤
廖坚甫
许智捷
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Bened Biomedical Co Ltd
Original Assignee
Fama Technology Consulting Co ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US14/259,442 external-priority patent/US10967013B2/en
Priority claimed from US14/690,502 external-priority patent/US10188684B2/en
Application filed by Fama Technology Consulting Co ltd filed Critical Fama Technology Consulting Co ltd
Publication of CN105002109A publication Critical patent/CN105002109A/zh
Application granted granted Critical
Publication of CN105002109B publication Critical patent/CN105002109B/zh
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A61K35/747—Lactobacilli, e.g. L. acidophilus or L. brevis
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/135—Bacteria or derivatives thereof, e.g. probiotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/10—Laxatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/12—Antidiarrhoeals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/14—Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/38—Drugs for disorders of the endocrine system of the suprarenal hormones
    • A61P5/46—Drugs for disorders of the endocrine system of the suprarenal hormones for decreasing, blocking or antagonising the activity of glucocorticosteroids
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20—Bacteria; Culture media therefor
    • C12N1/205—Bacterial isolates
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
    • C12R2001/00—Microorganisms ; Processes using microorganisms
    • C12R2001/01—Bacteria or Actinomycetales ; using bacteria or Actinomycetales
    • C12R2001/225—Lactobacillus
    • C12R2001/25—Lactobacillus plantarum

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biomedical Technology (AREA)
  • Microbiology (AREA)
  • Neurology (AREA)
  • Mycology (AREA)
  • Wood Science & Technology (AREA)
  • Neurosurgery (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • Pain & Pain Management (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Epidemiology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Nutrition Science (AREA)
  • Virology (AREA)
  • Molecular Biology (AREA)
  • Psychiatry (AREA)
  • Polymers & Plastics (AREA)
  • Food Science & Technology (AREA)
  • Rheumatology (AREA)
  • Endocrinology (AREA)
  • Diabetes (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Orthopedic Medicine & Surgery (AREA)
CN201510195767.9A 2014-04-23 2015-04-23 乳酸菌、包含该乳酸菌的组合物以及其用途 Active CN105002109B (zh)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US14/259,442 2014-04-23
US14/259,442 US10967013B2 (en) 2014-04-23 2014-04-23 Lactic acid bacterium for prophylaxis or treatment of a stress-induced disorder and a composition containing the same
US14/690,502 2015-04-20
US14/690,502 US10188684B2 (en) 2015-04-20 2015-04-20 Method for preventing or treating functional gastrointestinal disorder by lactic acid bacterium

Publications (2)

Publication Number Publication Date
CN105002109A CN105002109A (zh) 2015-10-28
CN105002109B true CN105002109B (zh) 2018-09-14

Family

ID=53008330

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201510195767.9A Active CN105002109B (zh) 2014-04-23 2015-04-23 乳酸菌、包含该乳酸菌的组合物以及其用途

Country Status (5)

Country Link
EP (1) EP2937424B1 (https=)
JP (1) JP6035578B2 (https=)
CN (1) CN105002109B (https=)
ES (1) ES2624673T3 (https=)
PL (1) PL2937424T3 (https=)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2020156417A1 (en) * 2019-01-28 2020-08-06 Bened Biomedical Co., Ltd. Method for protecting a subject for exercise

Families Citing this family (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP6933358B2 (ja) * 2016-04-06 2021-09-08 東海漬物株式会社 美肌促進剤
JP6878565B2 (ja) * 2016-07-19 2021-05-26 ベネド バイオメディカル カンパニー リミテッド 乳酸菌による大脳基底核疾患、または、チック障害を治療または予防するための薬剤
KR20180019474A (ko) * 2016-08-16 2018-02-26 주식회사 엠디헬스케어 락토바실러스 플란타룸 유래 소포를 포함하는 정신질환 예방 또는 치료용 조성물
CN107050062A (zh) * 2016-11-08 2017-08-18 江西益盟科技有限公司 治疗便秘的乳酸菌组合物及其制备方法
US11434468B2 (en) * 2017-01-13 2022-09-06 Bened Biomedical Co., Ltd. Lactic acid bacteria and its applications
KR102089836B1 (ko) * 2017-03-15 2020-03-16 (주)바이오일레븐 트립토판분해효소 음성균과 인터페론 감마 형성을 유도하는 균주를 이용한 염증성 질환 예방 및 치료용 약학적 조성물 또는 이를 이용한 치료방법
CN106906165B (zh) * 2017-04-25 2020-07-24 重庆第二师范学院 一种植物乳杆菌及其在制备预防便秘的食品中的应用
CN107267416A (zh) * 2017-07-05 2017-10-20 重庆第二师范学院 植物乳杆菌ys2及其在制备预防便秘的食品中的应用
WO2019119261A1 (en) * 2017-12-19 2019-06-27 Dupont Nutrition Biosciences Aps Probiotics for cognitive and mental health
JP7303811B2 (ja) * 2017-12-19 2023-07-05 デュポン ニュートリション バイオサイエンシーズ エーピーエス 認知的及び精神的健康のためのプロバイオティクス
BR112020015599A2 (pt) * 2018-02-02 2021-01-05 Kobiolabs, Inc. Cepa de lactobacillus plantarum kbl396 e uso da mesma
CN111035661A (zh) * 2018-10-15 2020-04-21 深圳市华大农业应用研究院 植物乳杆菌的用途
TWI731279B (zh) * 2018-11-21 2021-06-21 葡萄王生技股份有限公司 發酵乳桿菌gkf3、含其之組合物及改善精神失調之用途
ES2763350B2 (es) * 2018-11-28 2020-10-13 Consejo Superior Investigacion Cepa de christensenella minuta y uso de la misma
US20220040244A1 (en) * 2018-12-06 2022-02-10 Dupont Nutrition Biosciences Aps Probiotics for cognitive and mental health
BR112021014779A2 (pt) * 2019-02-01 2021-10-05 Institut National De Recherche Pour L'agriculture, L'alimentation Et L'environnement Cepas de lactococcus lactis para a prevenção e/ou o tratamento de dor visceral
BR112021014935A2 (pt) * 2019-02-01 2021-09-28 Bened Biomedical Co., Ltd. Método para prevenir ou tratar uma emoção ou comportamento anormal em um animal não humano por meio de bactéria ácido-láctica
KR102148707B1 (ko) * 2019-02-22 2020-08-31 한국식품연구원 우울증 및 불안장애의 예방, 개선 또는 치료 효능을 갖는 김치 유산균 락토바실러스 사케아이
WO2021155543A1 (en) * 2020-02-06 2021-08-12 Lee Wang Tso Composition of lactic acid bacterium for use in preventing or treating rett syndrome
CN115589775A (zh) * 2020-03-25 2023-01-10 益福生医股份有限公司 减少行为异常的方法
US20230390347A1 (en) * 2020-10-22 2023-12-07 Wang-Tso Lee Lactic acid bacterium for treatment of aromatic l-amino acid decarboxylase deficiency
TW202241477A (zh) * 2020-12-16 2022-11-01 日商明治股份有限公司 腦組織之發炎改善用組成物
CN113215018A (zh) * 2021-02-04 2021-08-06 郑州大学 一株植物乳杆菌植物亚种及其在豆粕和北艾混合发酵中的应用
CN113564084A (zh) * 2021-08-13 2021-10-29 华东理工大学 植物乳杆菌x7022在预防和治疗便秘上的应用
TWI810645B (zh) * 2021-09-06 2023-08-01 景岳生物科技股份有限公司 乳桿菌組合物及其改善抗生素造成之焦慮症的用途
KR20250095634A (ko) * 2022-10-28 2025-06-26 시에이치알. 한센 에이/에스 과민성 대장 증후군 증상 해결에 사용되기 위한 락티플란티바실러스 플란타룸
CN117143760B (zh) * 2023-07-12 2024-09-20 西南大学 一株能促进5-htp分泌及缓解抑郁的鼠李糖乳酪杆菌ky16及其应用
KR102741129B1 (ko) * 2023-11-07 2024-12-11 농업회사법인 고려홍삼원 주식회사 락토바실러스 플란타룸 ckh-01 균주를 포함하는 스트레스 완화 및 수면개선용 프로바이오틱스 조성물

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5725853A (en) * 1994-10-18 1998-03-10 Pioneer Hi-Bred International, Inc. 4 strain direct-fed microbial
US20050158294A1 (en) * 2003-12-19 2005-07-21 The Procter & Gamble Company Canine probiotic Bifidobacteria pseudolongum
US8669267B2 (en) * 2008-08-21 2014-03-11 Suntory Holdings Limited Pharmaceutical, food or beverage having inhibitory activity on serotonin transporter

Non-Patent Citations (5)

* Cited by examiner, † Cited by third party
Title
Diversity of lactic acid bacteria in suan-tsai and fu-tsai,traditional fermented mustard products of Taiwan;Shiou-Huei Chao等;《International Journal of Food Microbiology》;20091231;第135卷;203-210 *
Genome architecture of Lactobacillus plantarum PS128,a probiotic strain with potential immunomodulatory activity;Wei-Hsien Liu等;《Gut Pathog》;20150815;第7卷;1-7 *
Oral administration of Lactobacillus plantarum K68 ameliorates DSS-induced ulcerative colitis in BALB/c mice via the anti-inflammatory and immunomodulatory activites;Yen-Wenn Liu等;《International Immunopharmacology》;20111231;第11卷(第12期);2159-2166 *
γ-氨基丁酸发酵乳的研制;薛玉清等;《食品与发酵工业》;20131231;第39卷(第11期);85-90 *
植物乳杆菌的生理功能及应用;王水泉等;《中国农业科技导报》;20101231;第12卷(第4期);49-55 *

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2020156417A1 (en) * 2019-01-28 2020-08-06 Bened Biomedical Co., Ltd. Method for protecting a subject for exercise

Also Published As

Publication number Publication date
JP6035578B2 (ja) 2016-11-30
PL2937424T3 (pl) 2017-09-29
CN105002109A (zh) 2015-10-28
ES2624673T3 (es) 2017-07-17
JP2015213501A (ja) 2015-12-03
EP2937424B1 (en) 2017-03-29
EP2937424A1 (en) 2015-10-28

Similar Documents

Publication Publication Date Title
CN105002109B (zh) 乳酸菌、包含该乳酸菌的组合物以及其用途
KR101813881B1 (ko) 락트산 박테리아, 이를 함유하는 조성물 및 그의 용도
Roškar et al. Effects of a probiotic product containing Bifidobacterium animalis subsp. animalis IM386 and Lactobacillus plantarum MP2026 in lactose intolerant individuals: Randomized, placebo-controlled clinical trial
CN109661236A (zh) 设计的细菌组合物
TWI509070B (zh) 用於預防或治療壓力引發之失調的乳酸菌及包含該乳酸菌之組成物
BR112012030359B1 (pt) composição compreendendo pelo menos uma cepa de bactérias e método de seleção de cepas de bactérias
CN110527717A (zh) 用于2型糖尿病的生物标志物及其用途
JP6793380B2 (ja) スクロース摂取による血糖値上昇を抑制する物質の評価方法、スクリーニング方法及び製造方法
KR102480146B1 (ko) 인지능력 개선 기능을 가지는 락토바실러스 아시도필루스
De Bortolli Effects of supplementation with Lactobacillus probiotics on insomnia treatment
BR112020018047A2 (pt) Métodos para o alívio de um distúrbio gastrointestinal e da síndrome do intestino irritável e para melhorar a qualidade de vida de um indivíduo que sofre de síndrome do intestino irritável, método alternativo à terapia com fármacos para a prevenção e/ou tratamento da síndrome do intestino irritável, composições para o alívio de um distúrbio gastrointestinal e da síndrome do intestino irritável, e, uso de uma combinação
Guo et al. Chronic sacral nerve stimulation inhibits visceral hypersensitivity in diarrhea–predominant irritable bowel syndrome rats model
Karunanayake et al. Op‐7 therapeutic effects of domperidone on abdominal pain‐predominant functional gastrointestinal disorders: randomized, double‐blind, placebo‐controlled trial
Mccallum et al. Gastroparesis: pathophysiology, clinical presentation, diagnosis and treatment
Walter et al. OP‐12 PREVALENCE OF FUNCTIONAL CONSTIPATION IN INFANTS AND TODDLERS IN SRI LANKA
US20170360849A1 (en) Bacteria donors and pharmaceutical compositions
Chiba et al. The ROME II definition of dyspepsia does not exclude patients with gastroesophageal reflux disease (GERD) in primary care
Devanarayana et al. Op‐20 the association between adverse life events and abdominal pain‐predominant functional gastrointestinal disorders
Keetarut et al. OP‐16 DIETARY INTERVENTION USING THE LOW FODMAP DIET VERSUS THE “MILK, EGG, WHEAT AND SOYA FREE” DIET FOR TREATMENT OF FUNCTIONAL GUT DISORDERS A SINGLE CENTRE EXPERIENCE
Banasiuk et al. PP‐9 NORMAL VALUES OF 3D HIGH‐RESOLUTION ANORECTAL MANOMETRY IN CHIDREN
Yu et al. Advances in the mechanism and regulation of obesity induced by gut microbiota.
Hua Advanced Application of Bioinformatics in Gut Microbiota
Sintusek et al. OP‐2 THE DIAGNOSTIC VALUE OF RADIOLOGICAL COLONIC TRANSIT STUDY COMPARED WITH HIGH‐RESOLUTION COLONIC MANOMETRY.
Wang et al. Luminal Basic Science
Christian et al. OP‐22 PERCEPTIONS AND KNOWLEDGE ABOUT CONSTIPATION IN ARGENTINE PEDIATRICIANS. RESULTS OF A PRELIMINARY SURVEY.

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
GR01 Patent grant
GR01 Patent grant
TR01 Transfer of patent right

Effective date of registration: 20220418

Address after: Taiwan, Taipei, China

Patentee after: BENED BIOMEDICAL CO.,LTD.

Address before: Taichung City, Taiwan, China

Patentee before: Fama Technology Consulting Co.,Ltd.

TR01 Transfer of patent right